Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [906]
News [2550]
Articles [106]
Editorials [3]
Conferences [84]
elearning [20]
Immunotherapy for lung cancer before surgery
Dr. Luis Raez - Memorial Cancer Institute, Florida, USA
Immunotherapy for lung cancer before surgery ( Dr. Luis Raez - Memorial Cancer Institute, Florida, USA )
19 Jul 2019
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in...
Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in patients with advanced metastatic NSCLC ( Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA )
10 Jul 2019
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast...
Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer ( Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan )
10 Jul 2019
Gene expression in primary non-small cell lung cancer as a predictor of brain...
Dr Jair Bar - Sheba Medical Center, Tel Hashomer, Israel
Gene expression in primary non-small cell lung cancer as a predictor of brain metastases ( Dr Jair Bar - Sheba Medical Center, Tel Hashomer, Israel )
10 Jul 2019
Integration of DNA and RNA investigations in clinical trials: A laboratory...
Brandon Young - Bowden WIN Precision Oncology Laboratory, Murrieta, USA
Integration of DNA and RNA investigations in clinical trials: A laboratory challenge ( Brandon Young - Bowden WIN Precision Oncology Laboratory, Murrieta, USA )
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
The potential of PARP inhibitors in new cancer groups and in combination with...
Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston...
The potential of PARP inhibitors in new cancer groups and in combination with other treatments ( Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston, USA )
18 Jun 2019
Anti-tumour activity of TAK-788 in NSCLC patients with EGFR exon 20 insertions
Dr Joel Neal - Stanford University, Stanford, USA
Anti-tumour activity of TAK-788 in NSCLC patients with EGFR exon 20 insertions ( Dr Joel Neal - Stanford University, Stanford, USA )
18 Jun 2019
A phase II study of bemcentinib with pembrolizumab in patients with advanced...
Dr Enriqueta Felip - Vall d´Hebron Institute of Oncology (VHIO), Barcelona...
A phase II study of bemcentinib with pembrolizumab in patients with advanced NSCLC ( Dr Enriqueta Felip - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
11 Jun 2019
Pembrolizumab increases long-term survival in patients with advanced NSCLC
Dr Jorge Nieva - Keck School of Medicine of USC, Los Angeles, USA
Pembrolizumab increases long-term survival in patients with advanced NSCLC ( Dr Jorge Nieva - Keck School of Medicine of USC, Los Angeles, USA )
11 Jun 2019
Expanding clinical trial eligibility criteria: Risks and solutions
Dr Jorge Nieva - Keck School of Medicine of USC, Los Angeles, USA
Expanding clinical trial eligibility criteria: Risks and solutions ( Dr Jorge Nieva - Keck School of Medicine of USC, Los Angeles, USA )
11 Jun 2019
Carfilzomib and irinotecan in relapsed small cell lung cancer
Dr Susanne Arnold - UK Markey Cancer Center, Lexington, USA
Carfilzomib and irinotecan in relapsed small cell lung cancer ( Dr Susanne Arnold - UK Markey Cancer Center, Lexington, USA )
6 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation